SyntekaBio Inc (226330) — Capital Reinvestment Ratio

Latest as of December 2019: 0.06x

SyntekaBio Inc (226330) has a Capital Reinvestment Ratio of 0.06x as of December 2019, meaning it reinvests 0% of its operating cash flow (₩15.10 Billion) in capital expenditures (₩924.66 Million). See 226330 net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.06x

Capex / Operating Cash Flow

Operating Cash Flow

₩15.10 Billion

KRW

Capital Expenditures

₩924.66 Million

KRW

Data as of

Dec 2019

Most recent filing

Annual Capital Reinvestment Ratio for SyntekaBio Inc (None–None)

Year-by-year Capital Reinvestment Ratio for SyntekaBio Inc from None to None. For live market cap and broader valuation context, see SyntekaBio Inc stock valuation.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow